Project Grant R03AG105037
- The National Institute on Aging awarded the University of Texas at Austin $650,447 on September 1, 2026, under the Aging Research program (CFDA 93.866) to develop a profile-based framework for matching transitional care services to distinct patient-caregiver groups among persons living with dementia (PLWDs). The award funds research to identify patient-caregiver profiles and co-develop provider and system implementation tools that enable tailored, evidence-based transitional care delivery across...
- The National Institute on Aging awarded the University of Texas Health Science Center at Houston $312,000 on September 1, 2026, under the Aging Research program (CFDA 93.866) to revise and validate the Caregiver-Provider Relationship Assessment (CPRA), a measurement tool designed to evaluate interactions between family caregivers of individuals with Alzheimer's disease and related dementias and healthcare providers. The project will develop a psychometrically validated revision of the CPRA using...
- The National Institute on Aging, part of the Department of Health and Human Services, awarded The University of Texas Southwestern Medical Center $249,000 on September 1, 2026, under the Aging Research program (CFDA 93.866) to develop and validate an innovative genetic platform for de-risking g-secretase modulator therapeutics in Alzheimer's disease. The award funds two primary aims. Aim 1 involves using CRISPR/Cas9 engineering and structure-informed design to generate and validate a novel...
- The National Institute on Aging awarded Miami University $144,500 on June 15, 2026, under the Aging Research program (CFDA 93.866) to examine social factors that influence caregiver inclusion in older adult clinical appointments and identify which approaches to caregiver involvement produce optimal health outcomes. The project applies a person-centered analytic methodology to nationally representative data, conducting stage 0 activities under the NIH Stage Model to characterize social...
- The National Institute on Aging awarded New York University $3.053 million on September 1, 2026, under the Aging Research program (CFDA 93.866) to conduct longitudinal research on caregiving networks and their consequences among adults ages 85 and older. The award funds the ARIC CARES study, embedded within the Atherosclerosis Risk in Communities Study cohort. The research will characterize care ecosystems and relational coordination (teamwork) among family caregivers, paid caregivers, and...
- The National Institute on Aging awarded the University of Massachusetts Medical School $643,089 under the Aging Research program (CFDA 93.866) on September 30, 2025, to conduct objective medication self-administration (MSA) assessments as early-stage markers of cognitive impairment and Alzheimer's disease and related dementias (ADRD). The research will cross-sectionally and longitudinally associate MSA errors and self-overestimation with behavioral and brain-based ADRD biomarkers, cognitive...
- The National Institute on Aging awarded William Marsh Rice University $100,228 on December 4, 2026, under the Aging Research program (CFDA 93.866) to conduct research on the mental, physical, and immune health effects of negative emotional inertia and childhood trauma in dementia spousal caregivers. The research evaluates the role of emotional inertia—negative emotions that resist change over time—in caregiver self-reported health and immune function. The study assesses whether childhood...
- The National Institute on Aging awarded The University of Texas Health Science Center at San Antonio $1.112 million on September 20, 2025, under the Aging Research program (CFDA 93.866) to deliver advanced training in cross-national research on cognitive aging and Alzheimer's disease and related dementias using harmonized datasets from the Health and Retirement Study and the Harmonized Cognitive Assessment Protocol. The award funds five annual intensive courses for advanced-doctoral,...
- The National Institute on Aging awarded the University of Texas Health Science Center at Houston $312,000 on September 1, 2026, for Project Grant R03AG098212 under the Aging Research program (CFDA 93.866). The research investigates complement signaling in Alzheimer's disease pathogenesis, specifically the role of the complement component 3 receptor (C3AR1) in memory impairment and synaptic loss. The project examines whether ablation of microglial C3AR1, as distinct from neuronal C3AR1,...
- The National Institute on Aging awarded the University of Texas at Austin $10.686 million on September 15, 2025, under the Aging Research program (CFDA 93.866) to investigate remotely-supervised neuromodulation paired with language treatment for the logopenic variant of primary progressive aphasia, a progressive language disorder caused by underlying Alzheimer's disease pathology. The award supports research to enhance proven language treatment for LVPPA by combining it with tailored, home-based...
The National Institute on Aging awarded $156,000 to the University of Texas Health Science Center at Houston on September 1, 2026, under the Aging Research program (CFDA 93.866) to generate a theoretical model of family caregivers' decision-making around medication administration for behavioral symptoms of dementia. The recipient will conduct constructivist grounded theory research through in-depth interviews with 35 family caregivers of persons with Alzheimer's disease or related dementia, primarily drawn from participants in an ongoing R01 cohort who have reported chemical restraint or inappropriate medication use. The study pursues two specific aims: creating a typology characterizing caregivers' belief systems about medication use for behavioral symptom management, comparing prescribed versus non-prescribed practices; and constructing an empirically grounded, event-level process model describing caregivers' situational decision-making regarding medication administration. Findings will clarify the motivations, contextual pressures, and decision pathways that lead to safe versus unsafe medication practices. The period of performance runs from September 1, 2026, through August 31, 2028. Work is performed in Houston, Texas. The award is a Project Grant, the assistance type typically used for discrete, circumscribed projects of specified duration. UT Health receives the award as a child entity within the University of Texas System.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $156.0k | 8/14/26 |